Helene M Rasmussen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Placebo Controlled

Coronavirus Disease

Top Venues

Clinical and translational allergy

This page only lists publications with an associated author ORCID identifier.

Publications

Charlotte Gotthard Mortz, Louise Parke, Helene M Rasmussen, Henrik Fomsgaard Kjaer, Carsten Bindslev-Jensen
A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy. Allergy 79 (4) (2024)
Charlotte Gotthard Mortz, Louise Parke, Helene M Rasmussen, Henrik Fomsgaard Kjaer, Carsten Bindslev-Jensen
A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy. Allergy 79 (4) (2024)
Charlotte Gotthard Mortz, Louise Parke, Helene M Rasmussen, Henrik Fomsgaard Kjaer, Carsten Bindslev-Jensen
A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy. Allergy (2024)
Charlotte Gotthard Mortz, Louise Parke, Helene M Rasmussen, Henrik Fomsgaard Kjaer, Carsten Bindslev-Jensen
A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy. Allergy 79 (4) (2024)
Charlotte Gotthard Mortz, Louise Parke, Helene M Rasmussen, Henrik Fomsgaard Kjaer, Carsten Bindslev-Jensen
A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy. Allergy 79 (4) (2024)
Charlotte Gotthard Mortz, Henrik Fomsgaard Kjaer, Trine H Rasmussen, Helene M Rasmussen, Lene Heise Garvey, Carsten Bindslev-Jensen
Allergy to polyethylene glycol and polysorbates in a patient cohort: Diagnostic work-up and decision points for vaccination during the COVID-19 pandemic. Clinical and translational allergy 12 (1) (2022)